Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 87

    1.

    Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

    Korvatska O, Strand NS, Berndt JD, Strovas T, Chen DH, Leverenz JB, Kiianitsa K, Mata IF, Karakoc E, Greenup JL, Bonkowski E, Chuang J, Moon RT, Eichler EE, Nickerson DA, Zabetian CP, Kraemer BC, Bird TD, Raskind WH.

    Hum Mol Genet. 2013 Apr 28. [Epub ahead of print]

    PMID:
    23595882
    [PubMed - as supplied by publisher]
    2.

    Plasma apolipoprotein A1 as a biomarker for parkinson's disease.

    Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout D, Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, Chen-Plotkin AS.

    Ann Neurol. 2013 Feb 27. doi: 10.1002/ana.23872. [Epub ahead of print]

    PMID:
    23447138
    [PubMed - as supplied by publisher]
    3.

    CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration.

    Liachko NF, McMillan PJ, Guthrie CR, Bird TD, Leverenz JB, Kraemer BC.

    Ann Neurol. 2013 Feb 19. doi: 10.1002/ana.23870. [Epub ahead of print]

    PMID:
    23424178
    [PubMed - as supplied by publisher]
    4.

    APOE ε4 increases risk for dementia in pure synucleinopathies.

    Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP.

    JAMA Neurol. 2013 Feb;70(2):223-8. doi: 10.1001/jamaneurol.2013.600.

    PMID:
    23407718
    [PubMed - indexed for MEDLINE]
    5.

    DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.

    Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J.

    Sci Rep. 2012;2:954. doi: 10.1038/srep00954. Epub 2012 Dec 11.

    PMID:
    23233873
    [PubMed - in process]
    Free PMC Article
    6.

    Neuropsychologic assessment in collaborative Parkinson's disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

    Watson GS, Cholerton BA, Gross RG, Weintraub D, Zabetian CP, Trojanowski JQ, Montine TJ, Siderowf A, Leverenz JB.

    Alzheimers Dement. 2012 Nov 16. doi:pii: S1552-5260(12)02421-1. 10.1016/j.jalz.2012.07.006. [Epub ahead of print]

    PMID:
    23164549
    [PubMed - as supplied by publisher]
    7.

    Neuropathologic substrates of Parkinson disease dementia.

    Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ.

    Ann Neurol. 2012 Oct;72(4):587-98. doi: 10.1002/ana.23659. Epub 2012 Oct 4.

    PMID:
    23037886
    [PubMed - indexed for MEDLINE]
    8.

    GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.

    Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Trojanowski JQ, Schellenberg GD, Yearout D, Huston H, Fritts-Penniman A, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP.

    Neurology. 2012 Nov 6;79(19):1944-50. doi: 10.1212/WNL.0b013e3182735e9a. Epub 2012 Oct 3.

    PMID:
    23035075
    [PubMed - indexed for MEDLINE]
    9.

    Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease.

    Bekris LM, Millard S, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Yu CE, Peskind ER.

    Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):874-83. doi: 10.1002/ajmg.b.32094. Epub 2012 Aug 27.

    PMID:
    22927204
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    ADAM10 expression and promoter haplotype in Alzheimer's disease.

    Bekris LM, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Montine TJ, Peskind ER, Yu CE.

    Neurobiol Aging. 2012 Sep;33(9):2229.e1-2229.e9. doi: 10.1016/j.neurobiolaging.2012.03.013. Epub 2012 May 8.

    PMID:
    22572541
    [PubMed - indexed for MEDLINE]
    11.

    Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

    Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kövari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG.

    J Neuropathol Exp Neurol. 2012 May;71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7. Review.

    PMID:
    22487856
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Phosphorylated α-synuclein in Parkinson's disease.

    Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J.

    Sci Transl Med. 2012 Feb 15;4(121):121ra20. doi: 10.1126/scitranslmed.3002566.

    PMID:
    22344688
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function.

    Shi M, Furay AR, Sossi V, Aasly JO, Armaly J, Wang Y, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Leverenz JB, Stoessl AJ, Zhang J.

    Neurobiol Aging. 2012 Apr;33(4):836.e5-7. doi: 10.1016/j.neurobiolaging.2011.09.015. Epub 2011 Oct 21.

    PMID:
    22019052
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Truncation of tau at E391 promotes early pathologic changes in transgenic mice.

    McMillan PJ, Kraemer BC, Robinson L, Leverenz JB, Raskind M, Schellenberg G.

    J Neuropathol Exp Neurol. 2011 Nov;70(11):1006-19. doi: 10.1097/NEN.0b013e31823557fb.

    PMID:
    22002427
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment.

    Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M, Leverenz JB, Walter BK, Tsai E, Postupna N, Lampe J, Craft S.

    J Alzheimers Dis. 2012;28(1):137-46. doi: 10.3233/JAD-2011-111076.

    PMID:
    21971406
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

    Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B.

    Arch Neurol. 2012 Jan;69(1):29-38. doi: 10.1001/archneurol.2011.233. Epub 2011 Sep 12.

    PMID:
    21911655
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Ecology of the aging human brain.

    Sonnen JA, Santa Cruz K, Hemmy LS, Woltjer R, Leverenz JB, Montine KS, Jack CR, Kaye J, Lim K, Larson EB, White L, Montine TJ.

    Arch Neurol. 2011 Aug;68(8):1049-56. doi: 10.1001/archneurol.2011.157.

    PMID:
    21825242
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction.

    Hata S, Fujishige S, Araki Y, Taniguchi M, Urakami K, Peskind E, Akatsu H, Araseki M, Yamamoto K, Martins RN, Maeda M, Nishimura M, Levey A, Chung KA, Montine T, Leverenz J, Fagan A, Goate A, Bateman R, Holtzman DM, Yamamoto T, Nakaya T, Gandy S, Suzuki T.

    Ann Neurol. 2011 Jun;69(6):1026-31. doi: 10.1002/ana.22343.

    PMID:
    21681798
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.

    Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, Lampe J, Kahn SE, Craft S.

    Arch Neurol. 2011 Jun;68(6):743-52. doi: 10.1001/archneurol.2011.125.

    PMID:
    21670398
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy.

    Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J.

    Am J Pathol. 2011 Apr;178(4):1509-16. doi: 10.1016/j.ajpath.2011.01.006.

    PMID:
    21435440
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Search details

      See more...
      Write to the Help Desk